Ocera Therapeutics, Inc.
New Filing
CIK: 0001274644·Pharmaceuticals·DELAWARE·Filed: Jul 16, 2013
Total Offering
Indefinite
Amount Sold
$20,000,000
Investors
18
First Sale
Jul 15, 2013
Offering Details
- Type
- Equity
- Exemptions
- Rule 506
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Linda S. Grais | Related Person |
| Dana S. McGowan | Related Person |
| Nina Kjellson | Related Person |
| Michael F. Powell | Related Person |
| Pratik Shah | Related Person |
| Eckard Weber | Related Person |
| Lars Ekman | Related Person |
| Jean-Paul Castaigne | Related Person |
| Franck S. Rousseau | Related Person |
| David S. Moore | Related Person |
| Anne M. VanLent | Related Person |
Company
SEC Filing
0001274644-13-000021
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free